Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1.

Strizki, Julie M; Tremblay, Cecile; Xu, Serena; Wojcik, Lisa; Wagner, Nicole; Gonsiorek, Waldemar; Hipkin, R William; Chou, Chuan-Chu; Pugliese-Sivo, Catherine; Xiao, Yushi; Tagat, Jayaram R; Cox, Kathleen; Priestley, Tony; Sorota, Steve; Huang, Wei; Hirsch, Martin; Reyes, Gregory R; Baroudy, Bahige M

Strizki, Julie M; Tremblay, Cecile; Xu, Serena; Wojcik, Lisa; Wagner, Nicole; Gonsiorek, Waldemar; Hipkin, R William; Chou, Chuan-Chu; Pugliese-Sivo, Catherine; Xiao, Yushi; Tagat, Jayaram R; Cox, Kathleen; Priestley, Tony; Sorota, Steve; Huang, Wei; Hirsch, Martin; Reyes, Gregory R; Baroudy, Bahige M.

Affiliation

Strizki JM; Department of Antiviral Therapy, Schering-Plough Research Institute, 2015 Galloping Hill Road, K15, E405C/4945, Kenilworth, New Jersey 07033, USA. Julie.strizki@spcorp.com

Antimicrob Agents Chemother ; 49(12): 4911-9, 2005 Dec.

Article in En | MEDLINE | ID: mdl-16304152

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / HIV-1 / Anti-HIV Agents / CCR5 Receptor Antagonists Limits: Humans Language: En Journal: Antimicrob Agents Chemother Year: 2005 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google